BiohackingHealthcareScienceBioTech

Does Ozempic Raise Testosterone?

Barbell Medicine — Blog
Barbell Medicine — Blog•May 27, 2026

Why It Matters

GLP‑1‑induced weight loss can significantly raise testosterone, requiring clinicians to monitor and adjust hormone therapies to avoid over‑ or under‑treatment.

Key Takeaways

  • •10% weight loss raises testosterone ~84 ng/dL in men
  • •20‑30% weight loss via bariatric surgery adds ~250 ng/dL
  • •GLP‑1 agonists increase testosterone 20‑30% in obese men
  • •11% weight loss drops leptin 44%, boosting testosterone production
  • •Weight loss may require adjusting TRT or thyroid medication doses

Summary

The video examines whether Ozempic and other GLP‑1 receptor agonists raise testosterone in men, focusing on weight‑loss‑driven hormonal changes.

Data show a 10% body‑weight reduction lifts testosterone by roughly 84 ng/dL, while bariatric surgery‑induced 20‑30% loss can add about 250 ng/dL. GLP‑1 drugs such as semaglutide boost testosterone 20‑30% in obese males, a rise that tracks closely with the amount of weight shed and improved glycemic control. A study cited a 44% leptin decline after an 11% weight loss, underscoring leptin’s role in the HPG axis.

The hosts quote clinicians noting that men on GLP‑1 therapy should have testosterone rechecked at 3‑6‑12‑month intervals. They also discuss how patients already on testosterone replacement therapy may experience higher circulating levels as visceral fat falls, reducing aromatase activity and altering SHBG. Similar dose‑adjustments are common for thyroid hormone replacement during rapid weight loss.

For physicians, the takeaway is to anticipate hormonal shifts when prescribing GLP‑1 agonists and to schedule periodic lab monitoring, adjusting TRT or other endocrine doses as needed. Patients can expect ancillary benefits to sexual function and overall metabolic health, but must remain vigilant about potential overtreatment.

Original Description

Does Ozempic raise testosterone? Yes, and the data is more interesting than most lifestyle medicine podcasts have caught up to.
This segment from Episode 3 of our Signal book launch series covers the testosterone effect of GLP-1 receptor agonists in men with obesity, the mechanism by which it happens, and what to do clinically when a patient is already on semaglutide or tirzepatide and asks whether he should also be on testosterone. The short answer is that he is already on one of the most effective testosterone-raising medications available to him, and the lab number is probably climbing on its own.
Chapters:
00:00 Does Ozempic raise testosterone? Yes
00:30 The 20 to 30 percent effect
01:00 Mechanism: weight loss plus a likely direct effect
02:30 The GLP-1 patient who asks for TRT
04:00 The GLP-1 plus existing TRT case
Resources mentioned:
Signal book pre-order: https://barbellmedicine.com/signal
Barbell Medicine programs and coaching: https://www.barbellmedicine.com/
Episode 1 (Is the Testosterone Crisis Real?):
Episode 2 (Is Your Testosterone Actually Low?
Referenced studies:
Wu F.C.W. et al. 2010. Identification of late-onset hypogonadism in middle-aged and elderly men (EMAS). N Engl J Med 363(2):123-135.
Travison T.G. et al. 2011. The natural history of symptomatic androgen deficiency in men. J Am Geriatr Soc.
Corona G. et al. 2013. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: systematic review and meta-analysis. Eur J Endocrinol 168(6):829-843.
Kounatidis D. et al. 2025. The impact of GLP-1 receptor agonists on erectile function. Biomolecules 15(9):1284.
Grossmann M. et al. 2024. Testosterone treatment, weight loss, and health-related quality of life and psychosocial function in men: 2-year RCT (T4DM QoL arm). J Clin Endocrinol Metab 109(8):2019-2028.
Leproult R., Van Cauter E. 2011. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 305(21):2173-2174.
Penev P.D. 2007. Association between sleep and morning testosterone levels in older men. Sleep 30(4):427-432.
Wittert G. 2014. The relationship between sleep disorders and testosterone in men. Asian J Androl 16(2):262-265.
Alemany J.A. et al. 2008. Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity. J Appl Physiol 105(1):58-64.
Mountjoy M., Sundgot-Borgen J.K., Burke L.M. et al. 2018. IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. Br J Sports Med 52:687-697.
Areta J.L. et al. 2021. Low energy availability: history, definition and evidence of its endocrine, metabolic and physiological effects in prospective studies in females and males. Eur J Appl Physiol 121(1):1-21.
Mäestu J. et al. 2010. Anabolic and catabolic hormones and energy balance of the male bodybuilders during the preparation for the competition. J Strength Cond Res 24(4):1074-1081.
Hooper D.R. et al. 2018. Treating exercise-associated low testosterone (EHMC). Phys Sportsmed 46(4):427-434.
Hackney A.C. 2020. Hypogonadism in exercising males: dysfunction or adaptive-regulatory adjustment? Front Endocrinol 11:11.

Comments

Want to join the conversation?

Loading comments...